El balanç 2023 dels trasplantaments a l'#hbellvitge ens deixa el nombre de trasplantaments renals de donant viu més alt de l'Estat (51); el de cardíacs (21) i donants de teixits (345) més alt de Catalunya i un enorme agraïment a famílies i professionals
ℹ️https://t.co/cxpxRuJuIP
Abiertas inscripciones para formar parte del 3º Curso de Trasplante Renal de donante vivo #TRDV@SENTRAsplante
📍Madrid, 14-15 febrero 2025
🧑💻https://t.co/xQAdaCL0Yb
Gracias a la financiación de @ONT_esp y colaboración de @AstellasEurope
¡Apúntate hasta el 9 de diciembre!
Happy to share our latest study that gives some clues to improve the recovery of kidney function after transplantation. Severe ischemia-reperfusion injury induces epigenetic inactivation of LHX1 in kidney progenitor cells after kidney transplantation https://t.co/8oNyFfYhot
Como resumen: estructura, planificación y educación (¡tanto al paciente como a nosotros!). Si no estamos todos en esto, no podremos avanzar en nuestros objetivos con el trasplante de donante vivo
¿Cómo fomentar la educación?🧐
- Presencia de "paciente experto"
- Médicos generales: fomentar el apoyo al donante
- Sociedades: educación al paciente
- Gran papel de la enfermería
- Rotación de residentes en unidad de donante vivo
#Senefro24
Alcanzar un 20% de donante vivo dentro de los trasplantes sigue siendo un desafío:
- Un donante vivo es estudiado a más detalle que un cadáver
- Disparidad de género👫
- Diferencias en QoL entre donantes
- Educación insuficiente en la población general
La Dra. Maria Quero, nefròloga de l'#hbellvitge, ha presentat els resultats d’un innovador estudi multicèntric en el marc de l’American Society of Nephrology Kidney Week, un dels congressos de nefrologia més rellevants a escala mundial 👌
ℹ️https://t.co/pkU1L2LMOp
GLP-1 receptor agonists, which are effective for weight loss, can cause substantial muscle loss.
A Comment in @TheLancetEndo discusses the effects of GLP-1 receptor agonists on skeletal muscle mass: https://t.co/PySJT9uC7f
We are looking for a #PhDcandidate to present to current and future national and international calls for PhD opportunities.
Project scope: Pancreas transplant immunology
Project focus
--> Molecular Biology
--> Spatial cell-cell communication
Thanks to all centers involved in our study, including @MarcoAllinovi@AManonelles@crz_garrit and the collegues of the Gaslini Hospital. But most of the merit goes to Valentina Raglianti @ValentinaRagl1 and our microscopy artist @AngelottiLucia
Our new study is out! By STED microscopy on kidney biopsy and ELISA assays we show 1/3 of pediatric and half of adult patients (more in primary FSGS) have autoantibodies against slit antigens different from nephrin. i.e. anti-slit Abs
https://t.co/S8duyCNcL9
Look how much more important is to know if a patient is genetic or has anti-slit antibodies than if has MCD or FSGS at kidney biopsy.
We have finally come to the era of autoimmune, genetic and adaptive podocytopathies. No more MCD or FSGS used as diagnosis!
1/16) We are excited to share our recent paper “ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts” published today @Jclinicalinvest led by @KonradHoeft and @Lars_K0ch https://t.co/3JkwsN8eZ7
After years of sleepless nights in the hospital, this study only confirms how awful I feel after each one. The compensation and working conditions for on-call medical shifts in Spain are deplorable and deliberately ignored by health authorities. https://t.co/a417yIGv0E
Dapagliflozin treatment of patients with chronic kidney disease without diabetes across different albuminuria levels (OPTIMISE-CKD)
https://t.co/bHTjCPfksq